NasdaqGM - Delayed Quote USD

Keen Vision Acquisition Corporation (KVAC)

11.31
+0.01
+(0.09%)
As of May 21 at 4:00:00 PM EDT. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for KVAC

Recent News: KVAC

View More
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress

Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
GlobeNewswire 3 days ago
Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress

Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress
GlobeNewswire 10 days ago
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit

Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit
GlobeNewswire last month
Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction

Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction
GlobeNewswire 2 months ago
Medera Completes Patient Dosing for Heart Failure Treatment

Medera Completes Patient Dosing for Heart Failure Treatment
Exec Edge 2 months ago
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction

Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
GlobeNewswire 2 months ago
Medera’s Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, Utrecht

Medera’s Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, Utrecht
GlobeNewswire 3 months ago
Medera, Inc. to Participate in Two Upcoming Investor Conferences

Medera, Inc. to Participate in Two Upcoming Investor Conferences
GlobeNewswire 3 months ago
Medera’s Novoheart and Curi Bio Partner to Transform Human-Based Cardiac Drug Screening

Medera’s Novoheart and Curi Bio Partner to Transform Human-Based Cardiac Drug Screening
GlobeNewswire 5 months ago
Medera’s Novoheart Releases Latest Cardiac Screening Innovation CTScreen v1.5 to Advance High-Throughput, Automated Human-Based Drug Testing

Medera’s Novoheart Releases Latest Cardiac Screening Innovation CTScreen v1.5 to Advance High-Throughput, Automated Human-Based Drug Testing
GlobeNewswire 5 months ago
Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology

Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology
PR Newswire 6 months ago
View More

Related Tickers

MLAC Mountain Lake Acquisition Corp.
10.16
+0.10%
 
BSIIW
0.9000
+9.76%
 
SVIIW Spring Valley Acquisition Corp. II
0.1299
-5.87%
 
BSII Black Spade Acquisition II Co
10.39
+0.87%
 
SVII Spring Valley Acquisition Corp. II
11.66
0.00%